Prepare for Liver Disease and Tumors Test with tailored flashcards and questions. Get detailed explanations and improve your knowledge. Ace the medical student exam!

Multiple Choice

Portal vein thrombosis in cirrhotic patients with HCC may represent which of the following?

Portal vein thrombosis in a cirrhotic patient with hepatocellular carcinoma can arise from two different processes: bland thrombus and tumor invasion. Cirrhosis promotes bland thrombosis because portal blood flow is often sluggish and the coagulation balance is altered, making clot formation more likely. At the same time, hepatocellular carcinoma can extend into the portal venous system, producing a tumor thrombus composed of cancer cells within the vein. Because both mechanisms are possible in this scenario, the thrombus may be due to tumor invasion, bland thrombus, or a mixture of both. Imaging and clinical context help distinguish them, since tumor thrombus often shows enhancement within the thrombus on arterial-phase imaging and may track with the intrahepatic tumor, whereas bland thrombus typically does not enhance. This distinction matters because tumor thrombus carries a different prognosis and can influence treatment decisions, but it’s important to recognize that both possibilities can coexist in the same patient.

Portal vein thrombosis in a cirrhotic patient with hepatocellular carcinoma can arise from two different processes: bland thrombus and tumor invasion. Cirrhosis promotes bland thrombosis because portal blood flow is often sluggish and the coagulation balance is altered, making clot formation more likely. At the same time, hepatocellular carcinoma can extend into the portal venous system, producing a tumor thrombus composed of cancer cells within the vein. Because both mechanisms are possible in this scenario, the thrombus may be due to tumor invasion, bland thrombus, or a mixture of both.

Imaging and clinical context help distinguish them, since tumor thrombus often shows enhancement within the thrombus on arterial-phase imaging and may track with the intrahepatic tumor, whereas bland thrombus typically does not enhance. This distinction matters because tumor thrombus carries a different prognosis and can influence treatment decisions, but it’s important to recognize that both possibilities can coexist in the same patient.